Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA US

Walgreens Boots Alliance, Inc.USUnited States Composite

17.68

USD
+0.09
(+0.51%)
Walgreens Boots Alliance, Inc.
WBA
(United States Composite)

Recent

price

17.68

P/E

ratio

26.58

div

yld

10.87%

ROIC.AI

Business
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Company News

  • 2 Retail Pharmacy Stocks to Watch and One to Avoid Amid Industry Headwinds

  • Walgreens Boots Alliance Advances Global Health Equity Through Collaborative Partnerships

  • Walgreens Stock (NASDAQ:WBA): Tax Concerns Overblown, Says Analyst

  • Walgreens Boots Alliance stock dips on analysts' concerns

  • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q2 2024 Earnings Call Transcript

  • Company News for Apr 1, 2024

  • Company News for Apr 1, 2024

  • 1 Reason to Buy Walgreens, 1 Reason to Sell, and a Better High-Yield Stock to Buy Either Way

  • Walgreens CEO: 'We are on a mission to achieve provider status for our pharmacists'

  • Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says

  • Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?

  • Decoding Walgreens Boots Alliance Inc (WBA): A Strategic SWOT Insight

  • Q2 2024 Walgreens Boots Alliance Inc Earnings Call

  • Walgreens CEO says 'human interface' will help the chain beat Amazon

  • Asian Stocks to Open Higher After US Notches Gains: Markets Wrap

  • Why Walgreens Boots Alliance Stock Trounced the Market Today

  • S&P 500 Rises to New Record to Close Out Monster First Quarter

  • US STOCKS-S&P 500 closes higher to secure strongest Q1 since 2019

  • These Stocks Moved the Most Today: AMC, RH, MillerKnoll, Palantir, Trump Media, Estée Lauder, Braze, and More

  • US STOCKS-Equities poised to wrap up strong quarter on quiet note